Cargando…

Roles of osteoprotegerin in endocrine and metabolic disorders through receptor activator of nuclear factor kappa-B ligand/receptor activator of nuclear factor kappa-B signaling

Endocrine and metabolic diseases show increasing incidence and high treatment costs worldwide. Due to the complexity of their etiology and mechanism, therapeutic strategies are still lacking. Osteoprotegerin (OPG), a member of the tumor necrosis factor receptor superfamily, appears to be a potential...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Luodan, Zeng, Fa, Jiang, Minmin, Han, Maozhen, Huang, Binbin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671468/ https://www.ncbi.nlm.nih.gov/pubmed/36407115 http://dx.doi.org/10.3389/fcell.2022.1005681

Ejemplares similares

Role of osteoprotegerin/receptor activator of nuclear factor kappa B/receptor activator of nuclear factor kappa B ligand axis in nonalcoholic fatty liver disease
por: Pacifico, Lucia, et al.
Publicado: (2018)

Receptor activator of nuclear factor kappa B ligand and osteoprotegerin levels in gingival crevicular fluid
por: Sarlati, Fatemeh, et al.
Publicado: (2012)

Osteoprotegerin/Receptor Activator of Nuclear Factor-Kappa B Ligand/Receptor Activator of Nuclear Factor-Kappa B Axis in Obesity, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease
por: Vachliotis, Ilias D., et al.
Publicado: (2023)

Salivary soluble receptor activator of nuclear factor kappa B ligand/osteoprotegerin ratio in periodontal disease and health
por: Tabari, Zahra Alizadeh, et al.
Publicado: (2013)

Effect of Breastfeeding on Serum Osteoprotegerin and Soluble Receptor Activator of Nuclear Factor-Kappa B Ligand in Full Term Neonates
por: Rafeey, Mandana, et al.
Publicado: (2013)

What Is Nuclear Factor Kappa B (NF-κB) Doing in and to the Mitochondrion?
por: Albensi, Benedict C.
Publicado: (2019)

Regulation of Nuclear Factor-kappaB Function by O-GlcNAcylation in Inflammation and Cancer
por: Liu, Angela Rose, et al.
Publicado: (2021)

Effects of High and Low Doses of Folic Acid on the Soluble Receptor Activator of Nuclear Factor-kappa B Ligand/Osteoprotegerin Ratio during Pregnancy
por: FATHI MAROUFI, Nazila, et al.
Publicado: (2017)

Production of Soluble Receptor Activator of Nuclear Factor Kappa-Β Ligand and Osteoprotegerin by Apical Periodontitis Cells in Culture and Their Modulation by Cytokines
por: Duka, Miloš, et al.
Publicado: (2019)

Osteonecrosis of the jaw induced by receptor activator of nuclear factor-kappa B ligand (Denosumab) - Review
por: de Oliveira, Camila-Carvalho, et al.
Publicado: (2016)

Isoliquiritigenin Inhibits Metastatic Breast Cancer Cell-induced Receptor Activator of Nuclear Factor Kappa-B Ligand/Osteoprotegerin Ratio in Human Osteoblastic Cells
por: Lee, Sun Kyoung, et al.
Publicado: (2015)

Loading history changes the morphology and compressive force-induced expression of receptor activator of nuclear factor kappa B ligand/osteoprotegerin in MLO-Y4 osteocytes
por: Wang, Ziyi, et al.
Publicado: (2020)

Increased osteoclastic activity in acute Charcot’s osteoarthopathy: the role of receptor activator of nuclear factor-kappaB ligand
por: Mabilleau, G., et al.
Publicado: (2008)

In Rats, Whole and Refined Grains Decrease Bone Mineral Density and Content through Modulating Osteoprotegerin and Receptor Activator of Nuclear Factor Kappa B
por: Sakr, Hussein, et al.
Publicado: (2023)

Effect of Cornus Officinalis on Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL)-induced Osteoclast Differentiation
por: Kim, Jung Young, et al.
Publicado: (2012)

Immunohistochemical detection of the receptor activator of nuclear factor Kappa B ligand and c-fos in giant cell granuloma
por: Ahmed, Atif A, et al.
Publicado: (2016)

Impact of the Rapid Normalization of Chronic Hyperglycemia on the Receptor Activator of Nuclear Factor-Kappa B Ligand and the Osteoprotegerin System in Patients Living with Type 2 Diabetes: RANKL-GLYC Study
por: Dardari, Dured, et al.
Publicado: (2022)

Expression of osteoprotegerin, receptor activator of nuclear factor kappa-B ligand, tumor necrosis factor-related apoptosis-inducing ligand, stromal cell-derived factor-1 and their receptors in epithelial metastatic breast cancer cell lines
por: Labovsky, Vivian, et al.
Publicado: (2012)

Interleukin 37 Suppresses M1 Macrophage Polarization Through Inhibition of the Notch1 and Nuclear Factor Kappa B Pathways
por: Zhou, Peitao, et al.
Publicado: (2020)

Effects of the anti-receptor activator of nuclear factor kappa B ligand denusomab on beta thalassemia major-induced osteoporosis
por: Yassin, Mohamed A., et al.
Publicado: (2014)

Evaluation of the Receptor Activator of Nuclear Factor Kappa B Ligand (RANKL) Expression in Osteosarcoma and Its Association with the Clinicopathological Data
por: Chua, Hui Heng, et al.
Publicado: (2021)

Activation of Nuclear Factor-kappa B signalling promotes cellular senescence
por: Rovillain, Emilie, et al.
Publicado: (2011)

Isopsoralen suppresses receptor activator of nuclear factor kappa-β ligand-induced osteoclastogenesis by inhibiting the NF-κB signaling
por: Zhan, Wanda, et al.
Publicado: (2023)

Nuclear factor kappaB (NF-kappaB) pathway as a therapeutic target in rheumatoid arthritis.
por: Jue, D. M., et al.
Publicado: (1999)

Expression of Nuclear Factor Kappa B and Survivin in Psoriasis
por: Gunduz, Kamer, et al.
Publicado: (2012)

The dichotomy of inhibiting nuclear factor kappa-B in pneumonia
por: Abraham, Edward
Publicado: (2013)

Nuclear Factor-kappaB in Autoimmunity: Man and Mouse
por: Miraghazadeh, Bahar, et al.
Publicado: (2018)

Neuroinflammation in schizophrenia: the role of nuclear factor kappa B
por: Murphy, Caitlin E., et al.
Publicado: (2021)

Nuclear Factor-Kappa B Regulation of Osteoclastogenesis and Osteoblastogenesis
por: Boyce, Brendan F., et al.
Publicado: (2023)

Receptor activator of nuclear factor kappa-B gene polymorphisms in Iranian periodontitis and peri-implantitis patients
por: Kadkhodazadeh, Mahdi, et al.
Publicado: (2014)

Receptor-Activator of Nuclear KappaB Ligand Expression as a New Therapeutic Target in Primary Bone Tumors
por: Yamagishi, Tetsuro, et al.
Publicado: (2016)

The Values of Receptor Activator Nuclear Kappa-B Ligand Expression in Stage III Giant Cell Tumor of the Bone
por: Ghani, Sabrina Abdul, et al.
Publicado: (2018)

Glucocorticoid receptor and nuclear factor kappa-b affect three-dimensional chromatin organization
por: Kuznetsova, Tatyana, et al.
Publicado: (2015)

Receptor activator of nuclear factor kappa-B ligand (RANKL) but not sclerostin or gene polymorphisms is related to joint destruction in early rheumatoid arthritis
por: Boman, Antonia, et al.
Publicado: (2017)

Expression and Functional Evaluation of Recombinant Anti-receptor Activator of Nuclear Factor Kappa-B Ligand Monoclonal Antibody Produced in Nicotiana benthamiana
por: Boonyayothin, Wanuttha, et al.
Publicado: (2021)

Lophatherum gracile Bronghiart Suppresses Receptor Activator of Nuclear Factor Kappa-B Ligand-Stimulated Osteoclastogenesis and Prevents Ovariectomy-Induced Osteoporosis
por: Lee, Sung-Ju, et al.
Publicado: (2022)

Receptor activator of nuclear factor-κB ligand and osteoprotegerin: maintaining the balance to prevent bone loss
por: Trouvin, Anne-Priscille, et al.
Publicado: (2010)

Osteoprotegerin/receptor activator of nuclear factor-κB ligand are involved in periodontitis-promoted vascular calcification
por: Jiao, Mengyu, et al.
Publicado: (2022)

Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells
Publicado: (1992)

Receptor activator of nuclear factor-kappa B is enriched in CD9-positive extracellular vesicles released by osteoclasts
por: Ruan, Shaobo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0vrv7qrsbb2alkvseat7f4b4rs